Pivotal bioVenture Partners Investment Advisor LLC
Venture CapitalPosition in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1844645
SAN FRANCISCO, CA
Position in ARQT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$33,175,720
+$1,230,905 QoQ
Shares Held
1,265,283
-6.7% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
10.78%
of 13F equity value
Holder Rank
#23
of 269 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pivotal bioVenture Partners Investment Advisor LLC holds $291,774,212 across 12 Biotechnology names. ARQT ranks #2 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
1,425,470 | $82,862,571 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
1,265,283 | $33,175,720 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
|
1,742,672 | $32,500,832 | |
| 4 | AVLN |
Avalyn Pharma Inc.
|
966,792 | $31,826,792 | |
| 5 | EVMN |
Evommune, Inc.
|
1,926,943 | $25,609,072 | |
| 6 | MPLT |
MapLight Therapeutics, Inc.
|
611,446 | $21,914,224 | |
| 7 | OCS |
Oculis Holding AG
|
1,506,250 | $20,891,687 | |
| 8 | IMNM |
Immunome Inc.
|
732,512 | $15,521,929 |
All Filings in ARQT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,175,720 | 1,265,283 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $31,944,815 | 1,355,892 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $39,686,760 | 1,366,624 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $39,971,575 | 2,120,508 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $29,729,522 | 2,120,508 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $33,164,745 | 2,120,508 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $29,538,676 | 2,120,508 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $19,720,724 | 2,120,508 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $18,982,304 | 2,041,108 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $20,097,559 | 2,028,008 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,169,329 | 1,910,009 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,869,190 | 1,105,309 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,533,594 | 1,105,309 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,259,451 | 569,041 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,421,806 | 569,041 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,874,373 | 569,041 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $12,126,263 | 569,041 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,959,729 | 569,041 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,801,910 | 569,041 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,594,389 | 569,041 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,529,128 | 569,041 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $16,462,356 | 569,041 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $18,895,371 | 671,716 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||